We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rubella Susceptibility in Multiparous Women

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00401505
First Posted: November 20, 2006
Last Update Posted: April 25, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
  Purpose
The purpose of this study is to determine the reasons why multiparous women (women who are pregnant and have been pregnant before) might still be susceptible to rubella.

Condition
Rubella Vaccine

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Rubella Susceptibility in Multiparous Women

Resource links provided by NLM:


Further study details as provided by St. Michael's Hospital, Toronto:

Enrollment: 310
Study Start Date: September 2006
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Detailed Description:
This study is designed to investigate why multiparous women might still be susceptible to rubella. All pregnant women are checked for rubella immunity, and if they are non-immune, there are standard orders in our hospital to administer the rubella vaccine on the post-partum floor prior to discharge home from the hospital. Despite this, some multiparous women are found to be susceptible (non-immune), and this study will explore the reasons for this.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
All rubella susceptible women who delivered during the study period.
Criteria

Inclusion Criteria:

  • All rubella susceptible women who delivered during the study period.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00401505


Locations
Canada, Ontario
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark H Yudin, MD, MSc St. Michael's Hospital, Toronto
  More Information

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT00401505     History of Changes
Other Study ID Numbers: rubellain pregnancy
First Submitted: November 17, 2006
First Posted: November 20, 2006
Last Update Posted: April 25, 2016
Last Verified: April 2016

Keywords provided by St. Michael's Hospital, Toronto:
rubella
rubella vaccine
postpartum
immunity

Additional relevant MeSH terms:
Disease Susceptibility
Rubella
Disease Attributes
Pathologic Processes
Rubivirus Infections
Togaviridae Infections
RNA Virus Infections
Virus Diseases